ArticleVirus evolution2026
Intrahost population dynamics of chikungunya virus in humans and naturally infected
Article in Virus evolution, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Genetic diversity of the Chikungunya virus E2 gene may have implications for the design of vaccines and therapeutic antibodies.Virus genes · 2026Article
- Outbreak investigation of reemerging chikungunya virus in Malaysia in 2019-2020.BMC infectious diseases · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
15 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
RNA viruses exhibit a high mutation rate, contributing to their genetic diversity mainly because their RNA polymerase lacks proofreading ability. Arboviruses, which alternate between vertebrate and invertebrate hosts, are subjected to host-specific selective pressures and population bottlenecks, mainly within mosquito vectors. Although experimental studies have brought insights into their evolutionary dynamics, data from naturally infected vectors remain limited. Here, we investigated the intrahost genetic diversity of chikungunya virus (CHIKV-ECSA lineage) through whole-genome sequencing of 19 human- and 19 mosquito-derived genomes from the 2024 outbreak in São José do Rio Preto, Brazil. Our principal component analysis revealed a greater mutation number in mosquito-derived genomes, predominantly driven by low-frequency and unique variants. Overall, intrahost genetic diversity was significantly higher in mosquito-derived than in human-derived CHIKV genomes, and protein-coding regions showed host-specific patterns. We identified 303 mutations across all CHIKV genomes. Interestingly, shared mutations were predominantly classified as synonymous, whereas unique mutations were mainly nonsynonymous. Gene-wide selection analyses indicated that purifying selection predominates across CHIKV genomes from both humans and mosquitoes, suggesting that most mutations, particularly nonsynonymous ones, are deleterious and subject to purifying selection. However, in mosquito-derived CHIKV genomes, evidence of relaxed purifying selection and neutral evolution, in specific proteins, such as E3 and NSP3, respectively, was observed, in contrast to the stronger purifying selection observed in human-derived CHIKV sequences. Site-specific selection analyses corroborated these results, detecting negatively selected sites in human-derived genomes but not in mosquito-derived genomes for these specific proteins. Together, our results show that these host-specific differences enable mosquitoes to act as reservoirs of genetic diversity by maintaining nonsynonymous variants, likely driven by genetic drift. At the same time, human hosts may impose stronger selective pressures, contributing to preserving the genome stability. This dynamic balance between diversification in vector populations and selective constraints in vertebrate hosts likely drives CHIKV evolution and adaptation.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.